We are live on ! Find out more
CCG

Cypress Capital Group Portfolio holdings

AUM $889M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+27.23%
3 Year Est. Return
+83.89%
5 Year Est. Return
+113.23%
10 Year Est. Return
+324.61%
AUM
$691M
AUM Growth
+$39.9M
Cap. Flow
+$4.01M
Cap. Flow %
0.58%
Top 10 Hldgs %
28.55%
Holding
316
New
23
Increased
120
Reduced
134
Closed
18

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.34M
2
PFE icon
Pfizer
PFE
+$1.34M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.06M
4
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$996K
5
T icon
AT&T
T
+$986K

Sector Composition

Rank Sector Weight
1 Technology 20.38%
2 Healthcare 17.78%
3 Financials 10.27%
4 Consumer Discretionary 8.7%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
26
CME Group
CME
$92.5B
$6.53M 0.94%
35,223
-819
-2% -$151K
PEP icon
27
PepsiCo
PEP
$191B
$6.49M 0.94%
35,045
-2,527
-7% -$472K
BMY icon
28
Bristol-Myers Squibb
BMY
$128B
$6.36M 0.92%
99,496
-9,805
-9% -$657K
PSX icon
29
Phillips 66
PSX
$82.9B
$6.14M 0.89%
64,323
+545
+0.9% +$53K
SBUX icon
30
Starbucks
SBUX
$119B
$5.63M 0.81%
56,857
-4,773
-8% -$495K
NVDA icon
31
NVIDIA
NVDA
$4.75T
$5.25M 0.76%
124,120
-24,820
-17% -$824K
GOOG icon
32
Alphabet (Google) Class C
GOOG
$3.99T
$5.16M 0.75%
42,684
+1,886
+5% +$218K
MUB icon
33
iShares National Muni Bond ETF
MUB
$45.2B
$5.14M 0.74%
48,164
-1,440
-3% -$154K
MRK icon
34
Merck
MRK
$325B
$5.14M 0.74%
44,511
-11,827
-21% -$1.34M
COR icon
35
Cencora
COR
$60.7B
$4.96M 0.72%
25,780
-299
-1% -$51.7K
PM icon
36
Philip Morris
PM
$304B
$4.91M 0.71%
50,284
+3
+0% +$287
BLK icon
37
Blackrock
BLK
$163B
$4.81M 0.7%
6,961
-121
-2% -$81K
PXD
38
DELISTED
Pioneer Natural Resource Co.
PXD
$4.8M 0.69%
23,161
+13,339
+136% +$2.81M
ADBE icon
39
Adobe
ADBE
$95.1B
$4.78M 0.69%
9,767
-537
-5% -$216K
CSCO icon
40
Cisco
CSCO
$447B
$4.71M 0.68%
91,031
+6,346
+7% +$312K
COST icon
41
Costco
COST
$421B
$4.71M 0.68%
8,744
-1,148
-12% -$581K
PG icon
42
Procter & Gamble
PG
$346B
$4.57M 0.66%
30,112
-2,707
-8% -$408K
LMBS icon
43
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.35B
$4.54M 0.66%
95,205
-15,949
-14% -$764K
GILD icon
44
Gilead Sciences
GILD
$164B
$4.47M 0.65%
58,059
-3,371
-5% -$269K
CTRA
45
DELISTED
Coterra Energy
CTRA
$4.2M 0.61%
+166,181
New +$4.13M
PFE icon
46
Pfizer
PFE
$141B
$4.06M 0.59%
110,726
-34,488
-24% -$1.34M
NEE icon
47
NextEra Energy
NEE
$185B
$4.03M 0.58%
54,266
-1,947
-3% -$147K
GOOGL icon
48
Alphabet (Google) Class A
GOOGL
$3.99T
$3.98M 0.58%
33,227
+572
+2% +$65.8K
UNH icon
49
UnitedHealth
UNH
$380B
$3.86M 0.56%
8,033
+373
+5% +$182K
IAU icon
50
iShares Gold Trust
IAU
$63.3B
$3.7M 0.53%
101,543
-2,073
-2% -$77.7K

Similar funds

Cypress Capital Group's Q2 2023 Portfolio in Review

As of Q2 2023, Cypress Capital Group held 316 positions worth $691M, up 6.1% from $652M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cypress Capital Group's Q2 2023 filing shows 23 new, 120 increased, 134 reduced and 18 closed positions. Its largest new stake was Coterra Energy: 166,181 shares worth $4.2M. The largest sale was Merck, an estimated $1.34M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Cypress Capital Group's largest Q2 2023 buy was Coterra Energy: 166,181 shares worth $4.2M.
  • Cypress Capital Group added most to Pioneer Natural Resource Co. in Q2 2023, an estimated $2.81M increase.
  • Cypress Capital Group's biggest Q2 2023 reduction was Merck, cutting an estimated $1.34M.
  • Cypress Capital Group fully exited CF Industries in Q2 2023, selling an estimated $653K.
  • Cypress Capital Group's ten largest holdings make up 29% of its $691M portfolio in Q2 2023.
  • Cypress Capital Group opened 23 new positions and closed 18 in Q2 2023.
  • Cypress Capital Group's portfolio value rose 6.1% quarter-over-quarter to $691M.

Based on Cypress Capital Group's 13F filing for Q2 2023, filed 26 Jul 2023.